📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Pharmasset

1.1 - Company Overview

Pharmasset Logo

Pharmasset

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel oral therapeutics to treat viral infections, with a primary focus on hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV). Clinical-stage pharmaceutical company committed to discovering, developing, and commercializing antiviral drugs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Pharmasset

Infant Bacterial Therapeutics Logo

Infant Bacterial Therapeutics

HQ: Sweden Website
  • Description: Provider of clinical-stage pharmaceutical drug development focused on influencing the infant microbiome to prevent or treat rare diseases in infants. Developing IBP-9414 to prevent NEC in premature infants; IBP-9414 contains the active substance Lactobacillus reuteri, a human bacterial strain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Infant Bacterial Therapeutics company profile →
AdvanDx Logo

AdvanDx

HQ: United States Website
  • Description: Provider of rapid and accurate molecular in vitro diagnostic tests and kits for identifying pathogens causing critical infections in hospitalized patients, enabling healthcare providers to optimize antibiotic therapy earlier to improve patient outcomes while limiting unnecessary antibiotic use.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AdvanDx company profile →
Turn Therapeutics Logo

Turn Therapeutics

HQ: United States Website
  • Description: Provider of pharmaceutical solutions to reduce the human and economic costs of infection and skin disease, including PermaFusion petrolatum-based liquid-in-oil suspension technology for high-bioavailability delivery; Hexagen FDA-cleared antimicrobial wound dressing; a pre-operative nasal decolonization program targeting MRSA; and onychomycosis treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Turn Therapeutics company profile →
Tetraphase Pharmaceuticals Logo

Tetraphase Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapeutics for significant disease categories, including GIAPREZA to increase blood pressure in adults with septic or other distributive shock; XERAVA for complicated intra-abdominal infections in adults; XACDURO for hospital- and ventilator-associated bacterial pneumonia caused by susceptible Acinetobacter baumannii-calcoaceticus complex; and investigational zoliflodacin for uncomplicated gonorrhea.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tetraphase Pharmaceuticals company profile →
Targanta Therapeutics Logo

Targanta Therapeutics

HQ: United States Website
  • Description: Provider of innovative antibiotics and antibacterial therapies for serious infections treated or acquired in hospitals and other institutional settings, including oritavancin, an intravenous bactericidal agent for Gram-positive infections with Phase III trials for complicated skin and skin structure infections; antibacterial pro-drugs for osteomyelitis; and a drug discovery platform that mimics strategies devised by bacterial viruses to target druggable bacterial mechanisms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Targanta Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Pharmasset

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Pharmasset

2.2 - Growth funds investing in similar companies to Pharmasset

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Pharmasset

4.2 - Public trading comparable groups for Pharmasset

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Pharmasset

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Pharmasset

What does Pharmasset do?

Pharmasset is a provider of novel oral therapeutics to treat viral infections, with a primary focus on hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV). Clinical-stage pharmaceutical company committed to discovering, developing, and commercializing antiviral drugs.

Who are Pharmasset's competitors?

Pharmasset's competitors and similar companies include Infant Bacterial Therapeutics, AdvanDx, Turn Therapeutics, Tetraphase Pharmaceuticals, and Targanta Therapeutics.

Where is Pharmasset headquartered?

Pharmasset is headquartered in United States.

How many employees does Pharmasset have?

Pharmasset has 1,000 employees 🔒.

When was Pharmasset founded?

Pharmasset was founded in 2010 🔒.

What sector and industry vertical is Pharmasset in?

Pharmasset is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Pharmasset

Who are the top strategic acquirers in Pharmasset's sector and industry

Top strategic M&A buyers and acquirers in Pharmasset's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Pharmasset?

Top strategic M&A buyers groups and sectors for Pharmasset include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Pharmasset's sector and industry vertical

Which are the top PE firms investing in Pharmasset's sector and industry vertical?

Top PE firms investing in Pharmasset's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Pharmasset's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Pharmasset's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Pharmasset's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Pharmasset include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Pharmasset's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Pharmasset?

The key public trading comparables and valuation benchmarks for Pharmasset include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Pharmasset for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Pharmasset with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Pharmasset's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Pharmasset with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Pharmasset's' sector and industry vertical?

Access recent funding rounds and capital raises in Pharmasset's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Pharmasset